Search Results for: Shinya Yamanaka

Big stem cell news: dynamic duo of all-chemical direct reprogramming reports

/ / 8 Comments
Neurons-created-from-ciNSC

There’s some big, positive news on the stem cell front today. Two new innovative papers both by teams led by Sheng Ding of Gladstone Institutes with UCSF report all-chemical direct reprogramming of human somatic cells. Ding’s team took skin cells and by exposing them to cocktails of small molecules was able to turn them directly into […]

Big stem cell news: dynamic duo of all-chemical direct reprogramming reports Read More »

Stem cell good news briefs: TiGenix, Asterias, CIRM, Awards, & More

/ / 4 Comments
TiGenix

There’s a growing stream of stem cell good news of late. Stem cell biotech, TiGenix, reported encouraging Phase 3 allogeneic results on stem cells. A big milestone. I can’t wait to see the actual data. Its product, Cx601, has so far been safe and effective for perianal fistulas in Crohn’s disease. See more from Alexey on this. CIRM has funded the largest

Stem cell good news briefs: TiGenix, Asterias, CIRM, Awards, & More Read More »

Masayo Takahashi (高橋 政代) on IPSC Trial for Vision

/ / 9 Comments
Monkey-stem-cell-RPEs

Masayo Takahashi (高橋 政代) on IPSC Trial for Macular Degeneration By Michael Cea Stem Cell Analyst & Advocate (editor’s note: piece was originally posted on Michael’s blog here; follow Michael on Twitter @msemporda) Masayo Takahashi interview Having followed closely the developments in programs using pluripotent based therapeutics I was fortunate during ISSCR2015 to have the opportunity to

Masayo Takahashi (高橋 政代) on IPSC Trial for Vision Read More »

Biotech Talks #ISSCR2015: StemCells Inc, Semma, ViaCyte, & Le Blanc

/ / 1 Comment
Katarina-Le-Blanc

The path to the clinic is a slow and arduous activity, frustrating not only to the researcher and patient, but investors and biotech companies. Successful clinical translation of technologies requires a balance of science, streamlined translation and funding. To develop fantastic science and then realise the most important components cannot be adapted to the clinical

Biotech Talks #ISSCR2015: StemCells Inc, Semma, ViaCyte, & Le Blanc Read More »

Are babies from same-sex couples possible?

/ / 9 Comments
IPS-cell-cloning

A question that has come up with advances in stem cell technology: could same-sex couples have their own biological children? Since Shinya Yamanaka reprogrammed first mouse and then human ordinary cells into powerful pluripotent stem cells, termed induced pluripotent stem (iPS) cells, back in 2006-2007 many new research avenues have opened up. The impossible suddenly

Are babies from same-sex couples possible? Read More »

Stem Cell Person of the Year 2014: Masayo Takahashi (高橋 政代)

/ / 1 Comment
Monkey-stem-cell-RPEs

Congratulations to Masayo Takahashi (高橋 政代), MD, PhD, the winner of the 2014 Stem Cell Person of the Year Award. Dr. Takahashi received this award including the $2,000 prize for her exceptional achievements in stem cell research in 2014. She was selected as the winner from a stellar group of top 12 finalists this year. Takahashi leads

Stem Cell Person of the Year 2014: Masayo Takahashi (高橋 政代) Read More »

Landmark: patient receives first ever iPS cell based transplant

/ / 10 Comments
Masayo-Takahashi-150x150

In a major first for the stem cell and regenerative medicine fields, a patient in Japan today received a pioneering transplant of a retinal pigmented epithelial (RPE) sheet made from induced pluripotent stem (iPS) cells, also known by the acronym IPSC. This is the first ever iPS cell-based transplant into a human. The patient is

Landmark: patient receives first ever iPS cell based transplant Read More »